Access in all areas? A round up of developments in market access and health technology assessment: part 1-Reference-Cited by-同舟云学术

Access in all areas? A round up of developments in market access and health technology assessment: part 1

Published:2023-10 Issue:10 Volume:12 Page:
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:J. Comp. Eff. Res.

Author:

Gilardino Ramiro¹,Treharne Catrin²,Mardiguian Silvy³,Ramagopalan Sreeram V²⁴

Affiliation:

1. MSD Innovation & Development, Zurich, 8058, Switzerland

2. Lane Clark & Peacock, London, W1U 1DQ, UK

3. BeiGene, London, EC4A 4AB, UK

4. Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK

Abstract

In this new series reviewing recent developments in market access, we highlight publications investigating health technology assessment (HTA) guidance, review processes and outcomes across the world and discuss how forthcoming changes in the HTA and regulatory environment in the European Union may allow for more consistency in decision making.

Publisher

Becaris Publishing Limited

Subject

Health Policy

Link

https://becarispublishing.com/doi/pdf/10.57264/cer-2023-0129

Reference8 articles.

1. Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study;Jenei K;Lancet Oncol.,2023

2. What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries;Maynou L;Health Policy,2019

3. A review of HTA guidelines on societal and novel value elements;Breslau RM;Int. J. Technol. Assess. Health Care.,2023

4. Defining elements of value in health care – a health economics approach: an ISPOR Special Task Force Report [3];Lakdawalla DN;Value Health,2018

5. Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries;Post HC;ESMO Open,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?;Journal of Comparative Effectiveness Research;2024-06

2. Access in all areas? a round up of developments in market access and health technology assessment: part 4;Journal of Comparative Effectiveness Research;2024-06